Skip to content
Home/Companies/Biotech/Carrick Therapeutics
CT

Carrick Therapeutics

Biotech·Ireland·Active·5yr hold

Carrick Therapeutics is a biotech company, headquartered in UK.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Carrick Therapeutics?

Carrick Therapeutics is currently owned by Rosetta Capital through Rosetta Capital V (2021 vintage), since 2021. Across its history, Carrick Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-06-21

Rosetta Capital
Most recent investor
Rosetta Capital
Rosetta Capital V · 2021 · Secondaries
2 ownership periods · full history below

Key facts

HQUK
SectorBiotech
StatusActive

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Cambridge Innovation Capital and Rosetta Capital since 2016.
Co-invest · 2 holders · 2016 · present
Cambridge Innovation Capital
Cambridge Innovation CapitalActive
2016 · present · CIC Fund I · 2013 · VC
MOIC
–
Rosetta Capital
Rosetta CapitalActive
2021 · present · Rosetta Capital V · 2021 · Secondaries
MOIC
–

More from Rosetta Capital V

Other portfolio companies in the same fund.

Immunocore
Active
BiotechUK· 2021
Inivata
Active
HealthTechUK· 2021
Mereo BioPharma
Active
BiotechUK· 2021
Mission Therapeutics
Active
BiotechUK· 2021
PsiOxus Therapeutics
Active
BiotechUK· 2021
ReNeuron
Active
BiotechUK· 2021

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings